Table 3.
Summary of the drugs.
| +D−CAD (N = 23, n/%) | +D+CAD (N = 21, n/%) | −D+CAD (N = 26, n/%) | −D−CAD (N = 23, n/%) | |
|---|---|---|---|---|
| β blockers | 1 (4) | 15 (71) | 23 (86) | 0 (0) |
| ACE-inhibitors | 0 (0) | 17 (81) | 19 (73) | 0 (0) |
| AT1-antagonists | 0 (0) | 3 (14) | 6 (23) | 0 (0) |
| Ca-antagonists | 0 (0) | 4 (19) | 5 (19) | 0 (0) |
| diuretics | 0 (0) | 13 (62) | 9 (35) | 0 (0) |
| Statins | 1 (4) | 19 (91) | 24 (92) | 0 (0) |
| Antidepressants | 14 (61) | 5 (24) | 0 (0) | 0 (0) |
N & n, number; ACE: angiotensinconverting-enzyme; AT1: Angiotensin II receptor type 1; β: beta; Ca: calcium channel.